Dataset from An Open-label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Levetiracetam Used as Monotherapy in Newly or Recently Diagnosed Epilepsy Patients Aged Older Than or Equal to 16 Years With Partial Seizures
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00009849
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the efficacy of Levetiracetam (LEV) used as
monotherapy, with efficacy measured as 6-month seizure freedom at the last evaluated dose in
the LEV 1000 mg/day to 2000 mg/day group, in newly or recently diagnosed epilepsy subjects.
创建时间：
2026-03-16
